GLP-1 receptor agonists and cardiovascular disease: drug-specific or class effects?

被引：22
|
作者：
Zweck, Elric [1 ,2 ,3 ]
Roden, Michael [1 ,2 ,4 ]
机构：
[1] Heinrich Heine Univ Dusseldorf, Leibniz Ctr Diabet Res, German Diabet Ctr, Inst Clin Diabetol, D-40225 Dusseldorf, Germany
[2] German Ctr Diabet Res, Munich, Germany
[3] Heinrich Heine Univ, Fac Med, Div Cardiol Pulmonol & Vasc Med, Dusseldorf, Germany
[4] Heinrich Heine Univ, Fac Med, Div Endocrinol & Diabetol, Dusseldorf, Germany
来源：
LANCET DIABETES & ENDOCRINOLOGY | 2019年 / 7卷 / 02期
关键词：
D O I：
10.1016/S2213-8587(18)30351-6
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：89 / 90
页数：3
相关论文
共 50 条
  • [1] The Cardiovascular Effects of GLP-1 Receptor Agonists
    Okerson, Theodore
    Chilton, Robert J.
    CARDIOVASCULAR THERAPEUTICS, 2012, 30 (03) : e146 - e155
  • [2] GLP-1 receptor agonists and cardiovascular protection: A class effect or not?
    Scheen, Andre J.
    DIABETES & METABOLISM, 2018, 44 (03) : 193 - 196
  • [3] GLP-1 Receptor Agonists: Effects on Cardiovascular Risk Reduction
    Lorber, Daniel
    CARDIOVASCULAR THERAPEUTICS, 2013, 31 (04) : 238 - 249
  • [4] GLP-1 receptor agonists: A clinical perspective on cardiovascular effects
    Mundil, Dhanwantee
    Cameron-Vendrig, Alison
    Husain, Mansoor
    DIABETES & VASCULAR DISEASE RESEARCH, 2012, 9 (02): : 95 - 108
  • [5] Cardiovascular safety and GLP-1 receptor agonists
    Carty, David M.
    Drummond, Russell
    Fisher, Miles
    PRACTICAL DIABETES, 2013, 30 (06) : 242 - 245
  • [6] GLP-1 receptor agonists and cardiovascular safety
    Huang, Yu-Yao
    DIABETES RESEARCH AND CLINICAL PRACTICE, 2016, 120 : S20 - S20
  • [7] Cardiovascular safety and benefits of GLP-1 receptor agonists
    Dalsgaard, Niels B.
    Bronden, Andreas
    Vilsboll, Tina
    Knop, Filip K.
    EXPERT OPINION ON DRUG SAFETY, 2017, 16 (03) : 351 - 363
  • [8] Is cardioprotection with GLP-1 receptor agonists a class effect?
    Ryden, Lars
    Ferrannini, Giulia
    Mellbin, Linda
    EUROPEAN JOURNAL OF PREVENTIVE CARDIOLOGY, 2021, 28 (01) : 18 - 21
  • [9] GLP-1 receptor agonists: differentiation within the class
    Taylor, Simeon I.
    LANCET DIABETES & ENDOCRINOLOGY, 2018, 6 (02): : 83 - 85
  • [10] GI Effects of GLP-1 Receptor Agonists
    不详
    MEDICAL LETTER ON DRUGS AND THERAPEUTICS, 2023, 65 (1690): : 191 - 192
12345